5 minIn the past, most AI products focused primarily on "answering questions." However, in the high-stakes world of biopharmaceutical R&D, what truly matters is the ability to: Source credible data → Conduct deep analysis → Formulate research conclusions → Institutionalize team knowledge.
With this goal at its core, Pharmato Integras has undergone a comprehensive upgrade to become a more powerful, integrated research engine.
1. Enhanced Biopharmaceutical Data Capabilities
Pharmato now integrates an even broader spectrum of professional data sources, including:
-
Scientific Literature
-
Clinical Trial Data
-
Industry News and Corporate Announcements
-
Conference Abstracts (ASCO, ESMO, AACR, etc.)
-
Drug R&D and Pipeline Information
Every response provides clear citations, ensuring full traceability and verification. In the biopharma industry, AI must not only answer—it must answer with authority and evidence.
2. A Unified System for Daily Inquiry and Deep Research
The new Integras platform supports three core work scenarios:
-
Daily Inquiry: Rapid retrieval of professional information, such as the latest progress on a specific target, a drug's clinical trial status, or a company's pipeline layout.
-
Deep Exploration: Initiates multi-step, autonomous research for complex inquiries. The system automatically executes multi-source retrieval, cross-validation of evidence, information synthesis, and the generation of comprehensive research reports. It supports multi-agent AI collaboration and allows users to refine research directions mid-process.
-
Clinical Comparison: Specialized optimization for competitive analysis. Whether comparing ADC products, analyzing the competitive landscape of a specific target, or conducting clinical trial data head-to-head comparisons, the system automatically extracts key endpoints to output structured, analytical results.
3. AI Knowledge Base: One-Click Knowledge Retention
One of the most significant upgrades is the seamless integration of a knowledge management system.
-
Any content—including literature, web pages, news articles, data dashboards, or clinical trial information—can be added to your knowledge base with a single click.
-
For PubMed and clinical trials, the system automatically extracts full-text articles, PDF files, and critical trial data.
-
True Integration: Unlike traditional systems where uploading and querying are disconnected, Integras fully bridges the gap. Knowledge base content is directly utilized in AI responses, allowing for the hybrid citation of internal documents and external industry data.
4. Professional Literature and Visualization Tools
-
Full-Cycle Research: The new version supports full-text viewing, PDF downloads, and original citation tracking, creating a complete closed loop from discovery to reading.
-
Automated Visualization: Charts are no longer a manual task. Integras can directly generate timelines, bullseye diagrams, roadmaps, and complex research analysis charts within your responses, turning research findings into presentation-ready visuals instantly.
5. Model Flexibility and Knowledge Asset Management
-
Model Selection: Users can now freely switch between different AI models depending on the task at hand—whether you need rapid retrieval or complex logical reasoning.
-
History Management: A fully upgraded history module supports global search, keyword highlighting, favorites management, and categorical filtering, ensuring that historical research results become a permanent and searchable team asset.
The Bottom Line
Pharmato Integras 2.0 is more than just a list of new features. It represents a paradigm shift designed specifically for the biopharmaceutical workflow. By connecting the entire chain of data acquisition, deep research, clinical analysis, and knowledge retention, we are transforming AI from a simple chatbot into a genuine, professional partner in the drug discovery process.
